Tea Life halves operating profit outlook after overseas wellness impairment
The company approved a JPY 35 million impairment and now expects JPY 11.105 billion in sales and JPY 258 million in operating profit for the year ending July, down from JPY 11.983 billion and JPY 533 million. Management blamed US tariff policy, a worsening Middle East situation, weaker wellness channels and higher costs, while keeping its JPY 15 year-end dividend forecast unchanged.